Erste Asset Management’s Avidity Biosciences RNAM Stock Holding History

Erste Asset Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-36,000	Closed	-$2.6M	–	648
2025 Q4	$2.6M	Hold	36,000	–	–	0.02%	328
2025 Q3	$1.53M	Buy	+36,000	New	+$1.46M	0.01%	374
2023 Q3	–	Sell	-10,900	Closed	-$121K	–	578
2023 Q2	$121K	Hold	10,900	–	–	﹤0.01%	514
2023 Q1	$183K	Hold	10,900	–	–	﹤0.01%	494
2022 Q4	$247K	Hold	10,900	–	–	0.01%	481
2022 Q3	$182K	Hold	10,900	–	–	﹤0.01%	502
2022 Q2	$156K	Hold	10,900	–	–	﹤0.01%	526
2022 Q1	$197K	Buy	+10,900	New	+$185K	﹤0.01%	507

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Erste Asset Management's RNAM Position: Q1 2026 in Review

Erste Asset Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 36,000 shares — an estimated $2.6M sold.

Erste Asset Management first reported a position in RNAM in Q1 2022 and held it in 8 quarters. The position peaked at $2.6M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Erste Asset Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Erste Asset Management sold 36,000 Avidity Biosciences shares in Q1 2026, an estimated $2.6M.
Erste Asset Management first reported a position in Avidity Biosciences in Q1 2022 and held it in 8 quarters.
Erste Asset Management's Avidity Biosciences position peaked at $2.6M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Erste Asset Management's 13F filing for Q1 2026, filed 11 May 2026.